Pal, Sangita
Broad Institute · Harvard University · Center for Neuro-Oncology · Dana-Farber Cancer Institute
4 papers on CoChatORCID 0000-0002-4892-841X
Most cited papers
- Verified
Epigenetics and aging
Pal, S., & Tyler, J. K. (2016) · Science Advances
Epigenetics and DNA MethylationGenetics, Aging, and Longevity in Model Organisms
Cited by 860
- Verified
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., Rendo, V., Abdusamad, M., Lam, D., Davison, D., Pal, S., Currimjee, N., Hess, J., Pantel, S., Nag, A., et al. (2020) · Nature Genetics
CRISPR and Genetic EngineeringCancer-related Molecular Pathways
Cited by 285
- Verified
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system
So, J., Mabe, N. W., Englinger, B., Chow, K.-H., Moyer, S. M., Yerrum, S., Trissal, M. C., Marques, J. G., Kwon, J. J., Shim, B., et al. (2022) · JCI Insight
Glioma Diagnosis and TreatmentChromatin Remodeling and Cancer
Cited by 45
- Verified
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Rendo, V., Lee, E. Q., Bossi, C., Khuu, N., Rudek, M. A., Pal, S., Azazmeh, N., Rashid, R., Lin, J.-R., Cusick, M., et al. (2025) · Science Translational Medicine
Glioma Diagnosis and TreatmentCancer-related Molecular Pathways
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free